ArticleACG case reports journal2026
Acute Acalculous Cholecystitis Mimicry: Symptomatic Hepatic Infiltration From Chronic Lymphocytic Leukemia Presenting as Cholestatic Liver Injury.
Article in ACG case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in the United States. CLL can infiltrate the liver parenchyma or sinusoids, rarely causing symptomatic hepatic outflow obstruction or acute liver failure, making such complications difficult to recognize. We describe a patient with symptomatic, nonobstructive cholestatic liver injury due to CLL infiltration. A 53-year-old man with CLL diagnosed 4 years prior (Rai stage 0 at diagnosis), managed with observation, presented with 10 days of fever, nausea, vomiting, and diarrhea. Examination was significant for fever (39°C) and right upper quadrant tenderness with no hepatomegaly appreciated on palpation. Laboratory testing demonstrated leukocytosis and a cholestatic-predominant liver injury. Imaging demonstrated gallbladder wall thickening, splenomegaly with diffuse lymphadenopathy, a normal-appearing liver, and no biliary obstruction. Empiric antibiotics did not result in clinical improvement. The hospital course was complicated by worsening leukocytosis and elevation in inflammatory markers. Liver biopsy demonstrated portal and sinusoidal infiltration by small mature lymphocytes, consistent with CLL infiltration. The patient was discharged on hospital day 8 after biochemical and clinical improvement with pulse-dose dexamethasone. Allopurinol was initiated for tumor lysis prophylaxis. Combination therapy with obinutuzumab and venetoclax was initiated for Rai stage III CLL. Symptomatic manifestations of CLL-induced hepatic infiltration are extremely rare. In patients with cholestatic-predominant liver injury and negative biliary imaging, particularly with known CLL or unexplained splenomegaly/adenopathy, malignant hepatic infiltration should be considered early, and liver biopsy can be diagnostic and expedite definitive therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.